Lesions such as JAK2 mutations, CRLF2 rearrangements, and RAS pathway alterations are previously described in DS-ALL [66,67,68,69,70], but the simultaneous presence of multiple high-risk genomic abnormalities is exceedingly rare. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.